Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients

References

• Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79(2):263–282.
   PubMed Web of Science ®Google Scholar
• Smith MR, Saad F, Egerdie B, et al. Sarcopenia during androgen-deprivation therapy for prostate cancer. J Clin Oncol. 2012;30(26):3271–3276.
   PubMed Web of Science ®Google Scholar
• van Londen GJ, Levy ME, Perera S, et al. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit Rev Oncol Hematol. 2008;68(2):172–177.
   PubMed Web of Science ®Google Scholar
• Wall BA, Galvão DA, Fatehee N, et al. Reduced cardiovascular capacity and resting metabolic rate in men with prostate cancer undergoing androgen deprivation: a comprehensive Cross-Sectional investigation. Adv Urol. 2015;2015:976235.
   PubMedGoogle Scholar
• Basaria S, Muller DC, Carducci MA, et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer. 2006;106(3):581–588.
   PubMed Web of Science ®Google Scholar
• Kintzel PE, Chase SL, Schultz LM, et al. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy. 2008;28(12):1511–1522.
   PubMed Web of Science ®Google Scholar
• Stone P, Hardy J, Huddart R, et al. Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer (Oxford, England: 1990). 2000;36(9):1134–1141.
   PubMed Web of Science ®Google Scholar
• Gonzalez BD, Jim HSL, Small BJ, et al. Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison. Support Care Cancer. 2016;24(5):2201–2207.
   PubMed Web of Science ®Google Scholar
• Levy ME, Perera S, van Londen GJ, et al. Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study. Urology. 2008;71(4):735–739.
   PubMed Web of Science ®Google Scholar
• Huang YT, Li CC, Chou YH, et al. Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study. Int J Clin Pharm. 2019;41(4):993–1003.
   PubMed Web of Science ®Google Scholar
• Boevé L, Hulshof M, Verhagen P, et al. Patient-reported quality of life in patients with primary metastatic prostate cancer treated with androgen deprivation therapy with and Without concurrent radiation therapy to the prostate in a prospective randomised clinical trial; data from the HORRAD trial. Eur Urol. 2021;79(2):188–197.
   PubMed Web of Science ®Google Scholar
• Backx EMP, Hangelbroek R, Snijders T, et al. Creatine loading does not preserve muscle mass or strength During leg immobilization in healthy, young males: a randomized controlled trial. Sports Med. 2017; Aug47(8):1661–1671.
   PubMed Web of Science ®Google Scholar
• Podsiadlo D, Richardson S. The timed "Up & go": a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society. 1991;39(2):142–148.
   PubMed Web of Science ®Google Scholar
• Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–119.
   PubMed Web of Science ®Google Scholar
• Nightingale EJ, Pourkazemi F, Hiller CE. Systematic review of timed stair tests. J Rehabil Res Dev. 2014;51(3):335–350.
   PubMedGoogle Scholar
• Verdijk LB, Koopman R, Schaart G, et al. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab. 2007;292(1):E151–7.
   PubMed Web of Science ®Google Scholar
• Mezzani A, Agostoni P, Cohen-Solal A, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the exercise physiology section of the european association for cardiovascular prevention and rehabilitation. Eur J Cardiovasc Prev Rehabil. 2009;16(3):249–267.
   PubMedGoogle Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. 3
   PubMed Web of Science ®Google Scholar
• van Andel G, Bottomley A, Fosså SD, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44(16):2418–2424.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Bonke B, et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325.
   PubMed Web of Science ®Google Scholar
• Wang DXM, Yao J, Zirek Y, et al. Muscle mass, strength, and physical performance predicting activities of daily living: a meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11(1):3–25.
   PubMed Web of Science ®Google Scholar
• Gong J, Payne D, Caron J, et al. Reduced cardiorespiratory fitness and increased cardiovascular mortality After prolonged androgen deprivation therapy for prostate cancer. JACC CardioOncol. 2020;2(4):553–563.
   PubMedGoogle Scholar
• Shephard RJ. Maximal oxygen intake and independence in old age. Br J Sports Med. 2009 May;43(5):342–346.
   PubMed Web of Science ®Google Scholar
• Shevach J, Gallagher EJ, Kochukoshy T, et al. Concurrent diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. Front Oncol. 2015;5:129.
   PubMed Web of Science ®Google Scholar
• Andersen MF, Midtgaard J, Bjerre ED. Do patients with prostate cancer benefit from exercise interventions? A systematic review and Meta-Analysis. IJERPH. 2022;19(2):972.
   Google Scholar
• Chipperfield K, Brooker J, Fletcher J, et al. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review. Health Psychol. 2014;33(11):1288–1297.
   PubMed Web of Science ®Google Scholar
• Kenfield SA, Stampfer MJ, Giovannucci E, et al. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726–732.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The Self-Administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–163.
   PubMed Web of Science ®Google Scholar